Log in to save to my catalogue

Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac tro...

Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac tro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a09a2953c50e4da8ad9915dfa149ffac

Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients

About this item

Full title

Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients

Publisher

London: Nature Publishing Group UK

Journal title

Communications medicine, 2023-10, Vol.3 (1), p.154-14, Article 154

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background
MCL-1 is a prosurvival B-cell lymphoma 2 family protein that plays a critical role in tumor maintenance and survival and can act as a resistance factor to multiple anticancer therapies. Herein, we describe the generation and characterization of the highly potent and selective MCL-1 inhibitor ABBV-467 and present findings from a first-...

Alternative Titles

Full title

Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a09a2953c50e4da8ad9915dfa149ffac

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a09a2953c50e4da8ad9915dfa149ffac

Other Identifiers

ISSN

2730-664X

E-ISSN

2730-664X

DOI

10.1038/s43856-023-00380-z

How to access this item